Skip to main content
. 2019 Mar 26;10:559. doi: 10.3389/fmicb.2019.00559

Table 3.

MIC of the fluoroquinolone (ciprofloxacin and levofloxacin) and amino-acid substitutions in the QRDR of the gyrA, gyrB, and parC genes of panel strains.

MIC(μg/ml) Amino-acid substitutions in
CIP* LEV* gyrA parC gyrB
ESBL
 YMC2003/5/C86 128, R 32, R S81L E88K A677V
 YMC2003/1/R306 0.5, S 0.75, R S81L
OVER-EXPRESSED AMPCβ -LACTAMASE
 YMC2009/2/B6756 128, R 6, I S81L S81L
 YMC2012/7/R3167 256, R 8, R S81L S81L
OXA-TYPE CARBAPENEMASES
 YMC2011/7/R812 0.5, S 0.19, S
 YMC2012/1/R79 128, R 6, I S81L S81L
 YMC2011/2/C582 128, R 24, R S81L S81L
 YMC2012/9/R2209 256, R 16, R S81L S81L
METALLO-β-LACTAMASE
 YMC2013/3/R2081 128, R 6, I S81L S81L
NARROW-SPECTRUM β-LACTAMASE
 YMC2010/8/T346 0.25, S 0.19, S
NARROW-SPECTRUM OXACILLINASE
 YMC2009/2/B2968 0.12, S 0.125, S
*

MIC assay was performed using Disk diffusion technique and E-test for ciprofloxacin and levofloxacin, respectively.